Technology
Upcoming Earnings
Health

MeiraGTx

$19.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.81 (-3.95%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MeiraGTx and other stocks, options, ETFs, and crypto commission-free!

About

MeiraGTx Holdings plc Ordinary Shares, also called MeiraGTx, is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Read More Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-UPF1, Wet AMD, and Dry AMD. The company was founded by Robin Ali, Alexandria Forbes, and Richard Giroux on March 20, 2015 and is headquartered in New York, NY.

Employees
59
Headquarters
New York, New York
Founded
2015
Market Cap
557.27M
Price-Earnings Ratio
Dividend Yield
Average Volume
99.13K
High Today
$20.72
Low Today
$18.73
Open Price
$20.39
Volume
87.08K
52 Week High
$21.93
52 Week Low
$7.98

Collections

Technology
Upcoming Earnings
Health
Biotechnology
Medical
Therapy
2018 IPO
US

News

MarketBeatMar 8

Stock Price, News, & Analysis for MeiraGTx

MeiraGTx Holdings plc, an integrated clinical stage gene therapy company, develops various gene therapy products for the lives of patients suffering from acquired and inherited disorders.

42

Earnings

-$2.29
-$1.72
-$1.15
-$0.58
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.63 per share
Actual
Expected Mar 21, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.